IN
Live price temporarily unavailable.
Price history
Incyte (INCY) is a Health Care company in the S&P 500. Latest news and coverage below.
Recent News (11)
-
Incyte Corporation (INCY) vs. Revolution Medicines (RVMD): Which Biotech Stock Offers the Better KRAS Opportunity?
Incyte Corporation (INCY) vs. Revolution Medicines (RVMD): Which Biotech Stock Offers the Better KRAS Opportunity?
-
Incyte: Cheaper, Growing Faster, And The Market Keeps Paying Up For Amgen Incyte: Cheaper, Growing Faster, And The Market Keeps Paying Up For Amgen Trefis
-
Incyte: Cheaper, Growing Faster, And The Market Keeps Paying Up For Amgen Incyte: Cheaper, Growing Faster, And The Market Keeps Paying Up For Amgen Trefis
-
Better Bet Than Amgen Stock: INCY, NBIX Deliver More Better Bet Than Amgen Stock: INCY, NBIX Deliver More Trefis
-
Incyte Stock: Is Wall Street Bullish or Bearish?
Incyte Stock: Is Wall Street Bullish or Bearish?
-
Incyte Sales Growth Drives Share Price Gains
Incyte Sales Growth Drives Share Price Gains
-
Oppenheimer raises Incyte stock price target to $120 on revenue beat Oppenheimer raises Incyte stock price target to $120 on revenue beat
-
Incyte earnings beat by $1.10, revenue topped estimates
Incyte earnings beat by $1.10, revenue topped estimates
-
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology Agreement provides Incyte the rights to develop and commercialize ENHANZE® with its mutCALR development program and an option to nominate up to two additional targets SAN DIEGO, July 20, 2026 /PRNewsw…
-
Incyte to present Phase 1 cancer data at ESMO Congress
Incyte to present Phase 1 cancer data at ESMO Congress
-
More Health Care stocks
- ABBV AbbVie
- AMGN Amgen
- BIIB Biogen
- GILD Gilead Sciences
- MRNA Moderna
- REGN Regeneron Pharmaceuticals
- VRTX Vertex Pharmaceuticals
- A Agilent Technologies